Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2023 call → NOWe need to determine if the transcript describes a situation where the company is currently paying for something not yet earning, with a specific near-dated event that ends the wait, and management treats it as the main current work. Let's analyze. The transcript discusses the Heimbach acquisition. The company acquired Heimbach on August 31, 2023. They have one month of Heimbach results in Q3. They mention integration costs, purchase accounting adjustments, and that Heimbach is slightly dilutive to EPS. They expect it to become accretive in 2025. They have a clear line of sight into cost savings. They are paying for integration, but the benefit (accretive earnings) is expected in 2025, which is more than a year away? Actually, 2025 is about a year and a few months from now (Q3 2023). But the question asks for a specific near-dated event within roughly the coming year. The transcript says "expect acquisition will become accretive to earnings and cash flow in 2025." That is more than a year away. Also, the acquisition is already done, so they are not waiting for a specific event like a launch or opening; they are integrating an acquired business. The costs are integration costs, but the business is already earning revenue. They are not paying for something not yet earning; they are paying for integration of an existing business that is already generating revenue. The Heimbach operations added revenue and reduced operating income by $500k, but that is not a "waiting period" for a specific event. The benefit is expected in 2025, but that is not a near-dated event within the coming year. Also, the company is not describing a situation where they are paying for something that hasn't arrived; they are integrating an acquisition. The costs are transaction-related and integration, but the business is already operating. So this does not fit the phenomenon. Another possibility: AEC has programs like LEAP, 787, etc. They are investing in technology development. But that is normal investment. They mention "investing wisely today in technology development that will position the Company to profitably grow well into the next decade." That is not a specific near-dated event.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.